Antidepressants may lead to breast cancer
The first connection has to do with pharmaceutical antidepressants. "Estrogen receptor (ER)-positive" breast cancer accounts for 70% of all breast cancer cases. A 2016 investigation published in the Psychopharmacology Journal found that the chemical paroxetine, a SSRI (selective serotonin reuptake inhibitor) drug "was associated with a 620 percent increase in the rate of breast cancer in women who had taken it over a four-year period."
Paroxetine is also known under the brand names Paxil, Pexeva, Aropax, Seroxat, Sereupin and Brisdelle. The same study found bisphenol A, or BPA, in these brands. BPA is a known xenoestrogen. It should also be noted that pharmaceutical anti-depressant use in the United States rose by 400 percent between 1998 and 2008. It isn't surprising, then, that breast cancer rates rose during that time as well. (Related: Antidepressant Paxil, commonly precribed for depressed cancer patients, increases risk of breast cancer.)